
| Pair Name | Curcumin, Arsenic trioxide | ||
| Phytochemical Name | Curcumin (PubChem CID: 969516 ) | ||
| Anticancer drug Name | Arsenic trioxide (PubChem CID: 14888 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Curcumin, Arsenic trioxide | |||
| Disease Info | [ICD-11: 2A60.Z] | Acute myeloid leukemia | Investigative | |
| Gene Regulation | Down-regulation | Expression | JAK2 | hsa3717 |
| Down-regulation | Expression | STAT3 | hsa6774 | |
| Down-regulation | Expression | BCL2 | hsa596 | |
| Up-regulation | Expression | TP53 | hsa7157 | |
| Up-regulation | Expression | PSMD9 | hsa5715 | |
| Up-regulation | Expression | BAX | hsa581 | |
| In Vitro Model | KG-1a | Adult acute myeloid leukemia | Homo sapiens (Human) | CVCL_1824 |
| In Vivo Model | All mice were inoculated with KG1-a cells via the tail vein after pretreatment of 48 h, approximately 1.0×10⁷ cells per mouse. | |||
| Result | Our results suggested that curcumin and As2O3 combination therapy exerts more significant anti-leukemia effects in the treatment of AML than curcumin or As2O3 monotherapy by up-regulating p53 pathway and down-regulating the JAK2/STAT3 pathway. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation. J Cancer Res Clin Oncol. 2023 Jan;149(1):219-230. doi: 10.1007/s00432-022-04463-7. | Click |